Right ventricular dysfunction (RVD) after cardiac surgery is associated with ischemia and myocardial injury. While echocardiographic measures like Tricuspid Annular Plane Systolic Excursion (TAPSE) are frequently used to assess ventricular function, they have limitations in terms of accuracy. The pulmonary artery catheter remains the gold standard for assessing RVD. This dysfunction is associated with an increased risk of both renal and hepatic failure, complications that significantly affect patient outcomes. Doppler ultrasound has emerged as a valuable tool in predicting these complications, particularly in monitoring portal circulation and hepatic perfusion. This study aims to explore the association between portal flow pulsatility and RVD after cardiac surgery.
The postoperative right ventricular dysfunction (RVD) after cardiac surgery has been described since the 1990s. It is associated to various pathophysiological mechanisms, including ischemia from prolonged aortic clamping, cardioplegia defects, myocardial injury, and ischemia-reperfusion phenomena. Many studies have observed reduced right ventricular function intraoperatively through transthoracic echocardiographic parameters like TAPSE, fractional area change, and longitudinal strain. However, accurately assessing RVD is challenging, as these parameters can be affected post-surgery without indicating true ventricular failure. In this context, obtaining reliable and robust invasive hemodynamic measurements is crucial for accurate assessment of RVD. The pulmonary artery catheter (PAC), or Swan-Ganz catheter remains the gold standard, providing precise information on right ventricular systolic and diastolic function, pulmonary artery pressures, left ventricular end-diastolic pressure, venous oxygen saturation, and cardiac output. In cardiac surgery, venous congestion resulting from right ventricular dysfunction is closely associated with increased mortality, leading to renal and hepatic failure. Tools like Doppler ultrasound (of renal, portal, and hepatic veins) can predict renal failure risk. Researchers developed the VEXUS score in 2020 to assess this risk, and recent research found an association between 50% portal flow pulsatility and RVD. However, some aspects remain to be clarified, such as the significant association between portal venous flow pulsatility and altered TAPSE. This prospective study aims to examine the association between portal flow pulsatility and right ventricular dysfunction after cardiac surgery.
Study Type
OBSERVATIONAL
Enrollment
32
Transthoracic and Transesophageal echography within 24 hours post cardiac surgery in patients at risk for postoperative complications
CMC Ambroise Paré Hartmann
Neuilly-sur-Seine, Île-de-France Region, France
Measure of Portal Vein Flow Pulsality
Measured by pulsed Doppler and calculated by the following formula: FP = (Vmax - Vmin) / Vmax × 100.
Time frame: First 24 hours post cardiac surgery
Right ventricular (RV) function assessement
Right ventricular (RV) function will be assessed through invasive hemodynamic parameters measured by a pulmonary artery catheter.
Time frame: First 24 hours post cardiac surgery
RV dysfunction
Will be evaluated with echocardiographic parameters: 1. The systolic function is defined by the systolic excursion of the tricuspid annulus (TAPSE) \< 17 mm and/or the systolic velocity of the tricuspid annulus (S' wave) \< 9 cm/s. 2. Diastolic function is assessed by analyzing the tricuspid flow with pulsed tissue Doppler, where the E/A ratio is \< 0.8, or an E/A ratio between 0.8 and 2 associated with an E/E' ratio \> 6, or an E/A ratio \> 2 with a Tei index (TDE) \< 120 ms.
Time frame: Maximum 30 days post cardiac surgery
Venous congestion
Venous congestion is measured via central venous catheter, or by echocardiographic findings
Time frame: Maximum 30 days post cardiac surgery
Renal failure
Acute kidney injury (AKI) will be defined according to the KDIGO classification.
Time frame: Maximum 30 days post cardiac surgery
Liver failure
As defined 1. Hyperbilirubinemia \> 2 mg/dL 2. Elevated liver enzymes (AST \> 110 U/L and ALT \> 190 U/L)
Time frame: Maximum 30 days post cardiac surgery
Association Between Portal Flow and Postoperative Complications, Including Cardiac Tamponade
Evaluation of the occurrence of cardiac tamponade.
Time frame: Maximum 30 days post cardiac surgery
Association between Portal Flow and Postoperative complications, Including Cardiac arrhythmias
Evaluation of the occurrence of ventricular arrhythmias.
Time frame: Maximum 30 days post cardiac surgery
Association between Portal Flow and Postoperative complications, Including initiation of extracorporeal renal replacement therapy
Evaluation of the occurrence of the need for initiation of extracorporeal renal replacement therapy (RRT)
Time frame: Maximum 30 days post cardiac surgery
Association between Portal Flow and Postoperative complications, Including mechanical ventilation
Use of ventilatory support through mechanical ventilation
Time frame: Maximum 30 days post cardiac surgery
Association between Portal Flow and Postoperative complications, Including catecholamine administration
Evaluation of the occurrence of catecholamine administration
Time frame: Maximum 30 days post cardiac surgery
Association between Portal Flow and Postoperative complications, Including mortality
Mortality in the ICU and in the hospital
Time frame: Maximum 30 days post cardiac surgery
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.